0001493152-22-021321.txt : 20220804 0001493152-22-021321.hdr.sgml : 20220804 20220804161611 ACCESSION NUMBER: 0001493152-22-021321 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220711 FILED AS OF DATE: 20220804 DATE AS OF CHANGE: 20220804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Poirier Michael S. CENTRAL INDEX KEY: 0001812504 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37428 FILM NUMBER: 221136782 MAIL ADDRESS: STREET 1: 2042 CORTE DEL NOGAL STREET 2: SUITE B CITY: CARLSBAD STATE: CA ZIP: 92011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Qualigen Therapeutics, Inc. CENTRAL INDEX KEY: 0001460702 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263474527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2042 CORTE DEL NOGAL STREET 2: CARLSBAD CITY: CALIFORNIA STATE: CA ZIP: 92011 BUSINESS PHONE: (760) 918-9165 MAIL ADDRESS: STREET 1: 2042 CORTE DEL NOGAL STREET 2: CARLSBAD CITY: CALIFORNIA STATE: CA ZIP: 92011 FORMER COMPANY: FORMER CONFORMED NAME: RITTER PHARMACEUTICALS INC DATE OF NAME CHANGE: 20090402 4 1 ownership.xml X0306 4 2022-07-11 0 0001460702 Qualigen Therapeutics, Inc. QLGN 0001812504 Poirier Michael S. C/O QUALIGEN THERAPEUTICS, INC., 2042 CORTE DEL NOGAL CARLSBAD CA 92011 1 1 0 0 Chairman and CEO Stock Option (Right to Buy) 0.5136 2022-07-11 4 A 0 375000 0 A 2032-07-11 Common Stock 375000 375000 D Shares underlying the stock option vest over three years in equal annual installments from the date of grant. /s/ Michael S. Poirier 2022-08-04